# RA PHARMACEUTICALS INC (RARX)

> Institutional ownership reported to the SEC as of Q2 2020, from Form 13F filings. Source: https://holderbook.com/stocks/RARX/

- Reporting holders: 1
- Reported value: $32.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Daiwa Securities Group Inc.](https://holderbook.com/funds/1481045-daiwa-securities-group-inc/) | $32.0K | 266 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2020 | 1 | $32.0K |
| Q1 2020 | 150 | $2.5B |
| Q4 2019 | 152 | $2.4B |
| Q3 2019 | 120 | $1.1B |
| Q2 2019 | 119 | $1.3B |
| Q1 2019 | 123 | $900.3M |
| Q4 2018 | 95 | $642.4M |